EngVIPO
Financiado
Engineering Vascularized Implants for Personalised Osteochondral Tissue Regenera...
Engineering Vascularized Implants for Personalised Osteochondral Tissue Regeneration From medical imaging to pre clinical validation
Osteochondral Injuries (OCI) is a challenging yet common clinical problem for orthopaedic surgeons worldwide and is associated with multiple clinical scenarios ranging from trauma to osteonecrosis. Strategies for functional tissue...
Osteochondral Injuries (OCI) is a challenging yet common clinical problem for orthopaedic surgeons worldwide and is associated with multiple clinical scenarios ranging from trauma to osteonecrosis. Strategies for functional tissue regeneration at still far from the clinics and should endeavour to heal the subchondral bone and joint interface and hyaline cartilage. Enhancing the understanding of the mechanisms that underlie OCI holds the potential to unlock ground-breaking advancements in therapeutic interventions. EngVIPO tackles current challenges in the realm of biofabricated patient-specific implants with enhanced vascularity and functionality, concerning scientific expertise and collaborations with renowned institutions for OC tissue engineering, within the interdisciplinary domains of 3D computational modelling, advanced manufacturing, 3D in vitro models, and nanotechnology, and boosting clinical translation of the tissue engineered products. The project is focused on catapult knowledge exchange and create research synergies on the development of innovative biomaterials and bioinks, emerging technologies, biobanks and personalized medicine, for the complete regeneration and establishment of normal function of injured/diseased OC tissue. This will range from advanced biomaterials/scaffolds incorporating bioactive ions with osteogenic function, implementation of innovative manufacturing technologies, spheroids/organoids integrated into microfluidics, therapeutic biologicals and biobanks, in silico modelling, in vitro immunocompatiblity, to in vivo evaluation. Such innovative approach represents a significant advancement in the field of orthopedics, leading to improved participation of biobanks towards the development of advanced implants and patient outcomes, and setting new standards for personalized implant solutions.
ver más
30/09/2028
Líder desconocido
1M€
Duración del proyecto: 49 meses
Fecha Inicio: 2024-08-02
Fecha Fin: 2028-09-30
Fecha Fin: 2028-09-30
Línea de financiación: concedida
El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-08-02
Presupuesto
El presupuesto total del proyecto asciende a
1M€
Líder del proyecto
Líder desconocido